ScholarIQanswers from OpenAlex

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries

PaperCitations, authors & open-access status

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries have?

ScholarIQcitation count

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries published?

ScholarIQyear

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries has 2024 year in the ScholarIQ index.

What is the open-access status of Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries?

ScholarIQoa status

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries has gold oa status in the ScholarIQ index.

What is the DOI of Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries?

ScholarIQdoi

The DOI for Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries is on the source record.

What is the PMID of Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries?

ScholarIQpmid

The PMID for Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries is on the source record.

What is the OpenAlex record for Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries?

ScholarIQopenalex

The OpenAlex for Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial